CTNNBIP1 and ovarian carcinoma: To further explore the effect of CTNNBIP1 on chemotherapy sensitivity of ovarian cancer, we treated IGROV1 and OVCAR-8 cell lines selectively overexpressing CTNNBIP1 and their corresponding control cells with different concentrations of cisplatin for 48 h.